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ing by ElAbstract This study included 86 women presented with asymmetric breast densities, seen on either
routine screening or diagnostic mammogram.
The aim of this work was to review the diagnostic role of breast MRI in the assessment of the clin-
ical signiﬁcance and outcomes of asymmetric breast densities identiﬁed on mammograms.
All patients underwent clinical examinations, bilateral mammography, breast ultrasonography, and
MR mammography including dynamic contrast study.
Results: MRI showed asymmetric breast densities secondary to benign changes in 62 patients
(72%) and malignant lesions in 24 patients (27.9%).
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Asymmetric breast densities may be indicative of a developing
mass, variation of normal breast tissue, or it may reﬂect post-
operative change from a previous biopsy, hormone replace-
ment therapy or merely poor positioning (1,2).
The American College of Radiology (ACR), Breast Imag-
ing Reporting and Data System (BI-RADS) deﬁned four dif-
ferent types of asymmetric breast ﬁndings:
(1) Asymmetric Breast tissue: refers to a greater volume or
density of breast tissue in one breast than in the corre-
sponding area in the contra lateral breast.
(2) Densities seen in one projection: reﬂect a density seen in
only one mammographic projection.
(3) Architectural distortion: refers to a focal area of breast
tissue that appears distorted with no deﬁnable central
mass. Speculations radiate from a common point, and
there is an area of focal retraction and tethering of nor-
mal parenchyma.
(4) Focal asymmetric densities: refer to focal asymmetric
densities that are seen on two mammographic views
but cannot be accurately identiﬁed as a true mass
(2,3).
At the present time, conventional mammography and ultra-
sonography (US) are the most widely employed noninvasive
screening methods for detection and evaluation of asymmetric
breasts. However, these techniques may have limited sensitiv-
ity and speciﬁcity for the detection and diagnosis of breast
lesions.
Digital mammography has the potential to overcome some
of the limitations of conventional mammography; because of
the increased contrast and decreased image noise it is possible
to improve image quality (4–6).2. Aim of the work
The aim of this study was to investigate the role of breast MRI
in the evaluation of the clinical signiﬁcance and outcomes of
asymmetric breast densities identiﬁed on mammograms.
3. Patients and methods
This study included 86 women presented with asymmetric
breast densities, seen on either routine screening or diagnosticmammogram during the period from June 2006 to June 2008.
The patients’ age ranged from 24 to 67 years.
Forty eight of our patients were asymptomatic seen on rou-
tine screening, the other 38 patients were symptomatic pre-
sented with pain, discharge and/or palpable lumps.
3.1. Methods
All patients underwent clinical examinations, bilateral mam-
mography, breast ultrasonography, and MR mammography
including dynamic contrast study.
Breast MRI examinations were performed using a 1.5 T
MR scanner (Signa; General Electric Medical systems).
Patients were imaged in prone position with breasts hang-
ing dependently, within Phased array breast coil.
3.2. Examination protocol
For all patients, the following sequences were obtained:
Localizer; axial fast spoiled gradient echo.
Sagittal T1-weighted spin-echo imaging.
Sagittal fast short inversion recovery sequence (STIR).
Axial and Sagittal T2 images with fat saturation using fast
spoiled gradient-echo sequence (SPGR).
4. Contrast study
Rapid bolus injection of gadolinium dimeglumine (Magnivist)
was administered at a dose of 0.1 mmol/kg.
Multiphase dynamic sequences (Vibrant fast spoiled gradi-
ent echo) were acquired immediately, at 90 s, at 3 min and at
6 min after intravenous contrast injection.
Using a GE Advantage windows workstation with func
Tool software for image post processing, ROI measurement
of suspicious foci was performed for parametric color maps
to determine the lesion enhancement rate peak and time.
Lesions that are strongly and rapidly enhancing were dis-
played in red, whereas slowly or weakly enhancing lesions ap-
peared blue or green.
Automated Slope enhancement ratio curves (SER) were
obtained.
Sonographically guided biopsies were performed for 53 pa-
tients with solid lesions noted on MR ﬁne needle aspiration
and cytological examination was performed for three cases.
The other 30 patients were followed clinically, and Mammog-
raphy or ultrasonography for 20 months.
The role of MRI in assessment of asymmetrical breast densities 503On breast MRI suspicious malignant lesions were diag-
nosed on basis of the morphological features of the mass such
as spiculated borders, microlobulated margins, irregular
masses and breast stroma architectural distortion. Benign
breast masses were diagnosed based on their morphological
feature (smooth masses of wall deﬁned borders and absence
of surrounding breast stroma architectural distortion).
5. Results
Out of 86 women included in this study MRI showed asym-
metric breast density secondary to benign changes in 62 pa-
tients (72%) and malignant lesions in 24 patients (27.9%)
(Table 1).
5.1. Benign diagnosis (n = 62)
MRM demonstrated asymmetric densities secondary to asym-
metric breast tissue size in 16 patients (18.6%) with no under-
lying masses or cystic changes. Mammography follow up of
this group for 20 months showed no changes of the asymmet-
ric densities and no developing masses. (Fig. 1).
Breast MRI revealed asymmetric densities secondary to be-
nign lesions in 42 patients (48.8%); ﬁndings included ﬁbrocys-
tic changes in 14 patients (16.2%) (Fig. 2), in three patients
complicated cysts noted were manifested with thickened and
enhancing cyst walls; ﬁne needle aspirate cytological examina-
tions for the complicated cysts revealed no malignancy. Fibro-
cystic changes with ﬁbro adenomas were noted in two patients.
Other benign ﬁndings included ﬁbroadenosis in six patients
(0.06%) (Fig. 3), hormonally active tissue in one patient
(0.01%) (Fig. 4), dilated ducts in two patients (0.02%) and in-
tra mammary lymph nodes in six patients (Fig. 2). Benign tu-
mors were noted in 14 patients (16.2%), ﬁndings included ﬁbro
adenomas in 12 patients (13.9%); ﬁbroadenomas were noted
as multiple lesions in eight patients and as a solitary lesion
in two patients. Combined ﬁbrocystic changes and ﬁbroadeno-
mas were seen in two patients (Figs. 5 and 6). Other benign tu-
mors included phyllodes tumor in one patient and intra ductalTable 1 MRI ﬁndings in 86 patients with asymmetric breast
densities.
MRI ﬁndings No. of patients %
Asymmetric breast tissue 16 18.6
Benign diagnosis (n= 46) 46 53.4
I – Benign lesions
Fibrocystic changes 14 16.2
Fibro adenosis 6 0.6
Hormonally reactive tissue 1 0.01
Duct ectasia full of secretions 2 0.02
Intra mammary lymph nodes 6 0.06
II – Benign tumors
Fibro adenomas 12 0.13
Duct papilloma 1 0.01
Phyllodes tumor 1 0.01
Malignant tumors 24 27.9
Focal malignant lesions
(n= 30 in 23 patients)
23 26
Malignant changes in scar 1 0.01
Fig. 1 (A) Bilateral medio-lateral mammograms revealed asym-
metric breast densities. (B) Breast MRI of the same patient showed
asymmetric breast tissue with observed greater volume and density
of the left breast tissue as compared to the corresponding area in
the right breast with no masses or cysts seen.papilloma in one patient (Fig. 7). No malignancy was noted in
this group on follow up for 20 months.5.2. Malignant changes (n = 24)
MRM demonstrated asymmetric density secondary to malig-
nant lesions in 24 patients (27.9%) of these there were 30 focal
malignant lesions in 23 patients and recurrent scar tumor in
Fig. 2 Asymmetrical dense breast secondary to ﬁbrocystic diseases was better evaluated with MRM as cystic contents and wall thickness
and their pattern of enhancement allowed conﬁdent exclusion of malignancy.
Fig. 3 (A) MRM Axial 3D FSPGR revealed asymmetric breast density with multiple small enhancing nodules at the left
breast . . . proved to be ﬁbroadenosis. Intra mammary lymph node at outer quadrant left breast characterized by internal fat contents into
incidental intra mammary lymph node was noted at the outer quadrant of the left breast. (B and C) MRM: axial 3D FSPGR, sagittal
STIR of the left breast architectural distortion of the left breast, multiple small oval shaped masses bright on T2 weighted
images . . . biopsy revealed ﬁbroadenosis.
Fig. 4 Hormonally reactive tissue, MRM showed localized region of enhancement. Dynamic study revealed benign type of enhancement
with delayed plateau . . . Biopsy conﬁrmed benign changes.
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Fig. 5 (A and B) Multiple ﬁbro adenomas seen as well circumscribed lesions showing hyper intense signals on T2 fat suppression images.
Lesion 1 showed slow enhancement with delayed plateau (typical for ﬁbroadenoma). Lesion 2 showed early strong enhancement with
delayed plateau.
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Fig. 6 Asymmetric breast density due to small oval shaped well deﬁned ﬁbroadenoma at the left breast exhibits hyper intense signals on
sagittal STIR image with slow progressive enhancement on dynamic study.
Fig. 7 Breast MRI axial T2 weight image and sagittal FSPGR left breast showed a large well – circumscribed mass of smooth margin
with central cystic components. On US the lesions showed well deﬁned outline, low echogenicity and central cystic components. Biopsy of
the lesion conﬁrmed benign phyllode tumor. The lesion showed type II temporal enhancement curve (early strong enhancement within ﬁrst
2 min and subsequent plateau.
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Fig. 8 MR Conﬁrmed asymmetrical density revealed an irreg-
ular mass lesion (carcinoma) at the left breast showing character-
istic early strong enhancement with subsequent wash out.
The role of MRI in assessment of asymmetrical breast densities 507one patient, malignant lesions were diagnosed on MRI based
on combined morphological features (as irregular shape,
masses with speculated borders) and dynamic enhancement
curves of the lesions.
Histopathological ﬁndings conﬁrmed malignancy in all the
suspicious lesions, there were no false positive MRI malignant
lesions (Fig. 8).6. Discussion
Our study was designed to evaluate the utility of breast MRI
for the detection of occult solid and cystic lesions in patient
with asymmetric dense breasts and also for characterization
of lesions detected on mammograms.
In the literatures asymmetric breast tissues were reported to
be almost benign while focal asymmetric densities may repre-
sent masses with borders that are either ill-deﬁned or obscured
by surrounding ﬁbroglandular tissue rather than asymmetric
tissue (7–9).
In agreement with the literatures, the majority of the pa-
tients, included in this study with asymmetric density identiﬁed
on mammograms (72%), had benign mammary changes, while
27.9% had malignant breast lesions.
In this study breast MRI conﬁrmed asymmetric densities to
be secondary to asymmetric breast tissue size in 23.2% of our
patients and no underlying masses or cysts were
detected.Fibrocystic changes represented the most common
cause of mammographic asymmetric breast densities, onMRI the lesions appeared as well deﬁned cystic lesions of var-
iable sizes that showed smooth wall with no enhancement;
complicated cysts showing wall enhancement and or thicken-
ing was indicative for ﬁne needle aspirations and cytological
examinations. Breast mammography showed relatively low
sensitivity in such patient with dense breasts. Fibrocystic
changes can be well evaluated by ultrasonography, however,
associated benign breast changes or hidden malignant lesions
could be missed on ultrasonography (9–11). So still, MRI
has a role in the diagnosis of ﬁbrocystic disease to exclude
unexpected associated malignant lesions.
Fibroadenosis was also a common benign cause of asym-
metric breast densities, which was encountered in this study
in 0.6% of our cases. On U/S the ﬁbro adenosis appeared as
multiple focal hypoechoic lesions of discrete outlines, which
represent areas of lobular hyperplasia (adenosis) interspersed
with bands of connective tissue ﬁbrosis (sclerosis). On MRI
it appeared as small oval or lobulated masses of sizes around
10 mm or less, the lesions showed delayed plateau type of
enhancement.
Fibro adenoma appeared as well deﬁned masses that
showed delayed plateau of enhancement, some lesions showed
non enhancing internal septation (7,10,11).
Intraductal papilloma appeared as smooth rounded
enhancing mass of morphologically benign feature showing ra-
pid enhancement and wash out with non speciﬁc MRI ﬁnd-
ings, ﬁnal diagnosis was made after biopsy.
Multiple distended ﬂuid ﬁlled ducts showed no enhance-
ment noted mainly at the retro areola appeared hyper intense
on T2 weighted sequences.
Intra mammary lymph nodes appear as rounded or longitu-
dinal shaped masses containing fat which is the clue for MRI
diagnosis (7,12).
In this study asymmetric breast density was secondary to
malignant lesions in 27.9%. Breast MR allowed better charac-
terizations of the lesions by their morphological features, irreg-
ular outlines, speculation and by enhancement pattern where
malignant lesion showed intense early enhancement with the
ﬁrst 2 min after contrast administration with subsequent wash
out. Also MRI allowed evaluation of involved important
lymph node groups at axillary and along the internal mam-
mary arteries regions.
Findings in recent studies (7,11) with state-of-the-art tech-
nology show the ability of breast MRI to depict an occult
malignancy in women with dense breast tissue.
Our results indicate that breast MRI can be an effective ad-
junct imaging examination in the evaluation of women with
asymmetric dense breast tissue at mammography.7. In conclusion
An important advantage of MR imaging compared with con-
ventional techniques (Mammography and US) is that it allows
more conﬁdent management in patients with asymmetric
dense breast parenchyma, especially in cases with negative
ﬁndings.
Benign-appearing ﬁndings on mammography can be better
evaluated with MRI, so enhancing foci or masses in these pa-
tients are better characterized and cannot be easily missed
(13,14).
508 H.A. Badawi, A.A.A. HassanAlso breast MR allows better characterization of highly
probable malignant lesions. Combined morphological feature
and dynamic enhancement pattern of the lesions allowed in-
creased sensitivity, and accuracy for lesion characterizations.
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